Postoperative Clinical Features of High‐Grade Squamous Intraepithelial Neoplasia Dominated by Cytological Atypia After Endoscopic Submucosal Dissection
Journal of Digestive Diseases · 2026-03 · 27 (3-4) · 139-149
DOI: 10.1111/1751-2980.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, online erschienen am 02.06.2026. Verfasst von Huan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Esophageal Neoplasms, Postoperative Complications, Squamous Intraepithelial Lesions. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Outstanding Talent Pool Key Support Object Projects of Army Medical University, Clinical Research Personnel Training Program.
Abstract (Originalsprache)
Objectives
Despite the relatively comprehensive understanding of esophageal high‐grade intraepithelial neoplasia (HGIN), clinical characteristics of HGIN dominated by cytological atypia after endoscopic submucosal dissection (ESD) remain unclear. We aimed to investigate the postoperative features and adverse events of patients with this pathological feature after ESD.
Methods
We retrospectively analyzed the data of 160 patients who underwent ESD for HGIN from 2018 to 2019. The patient cohort was divided into two groups based on the histopathology of the resected lesions: dominated by architectural atypia (HGINa) and cytological atypia (HGINc). Information on postoperative adverse events (fever, perforation, hemorrhage, and esophageal stricture) and second‐stage endoscopic treatments was collected. Follow‐up was conducted until December 2024 to analyze postoperative new‐onset neoplasia between the two groups. Binary logistic regression analyses were used to assess risk factors for postoperative adverse events.
Results
Among all included patients, 43 (26.88%) and 117 (73.12%) were classified as having HGINc and HGINa, respectively. The rates of postoperative fever and new‐onset neoplasia were significantly higher in the HGINc group than in the HGINa group (both p < 0.05), and HGINc emerged as an independent risk factor for these outcomes. Muscularis propria injury and mucosal defect exceeding 75% of the circumference were associated with postoperative esophageal stricture.
Conclusion
Post‐ESD management should focus on fever and new‐onset neoplasia in patients with HGINc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Department of Gastroenterology, The 901 Hospital of Chinese People's Liberation Army Joint Service Support Unit, Hefei, Anhui Province, China.
- Department of Burns and Wound Repair, The General Hospital of Xizang Military Area Command, Lhasa, Xizang Autonomous Region, China.
Förderung
- Outstanding Talent Pool Key Support Object Projects of Army Medical University
- Clinical Research Personnel Training Program
Zitieren
APA
Yang, H., Liao, G. B., Wang, L., Lin, H., & Bai, J. Y. (2026). Postoperative Clinical Features of High‐Grade Squamous Intraepithelial Neoplasia Dominated by Cytological Atypia After Endoscopic Submucosal Dissection. Journal of Digestive Diseases, 27(3-4), 139-149. https://doi.org/10.1111/1751-2980.70056
Vancouver
Yang H, Liao GB, Wang L, Lin H, Bai JY. Postoperative Clinical Features of High‐Grade Squamous Intraepithelial Neoplasia Dominated by Cytological Atypia After Endoscopic Submucosal Dissection. Journal of Digestive Diseases. 2026;27(3-4):139-149. doi:10.1111/1751-2980.70056
BibTeX
@article{Yang2026,
author = {Yang, Huan and Liao, Guo Bin and Wang, Liang and Lin, Hui and Bai, Jian Ying},
title = {Postoperative Clinical Features of High‐Grade Squamous Intraepithelial Neoplasia Dominated by Cytological Atypia After Endoscopic Submucosal Dissection},
journal = {Journal of Digestive Diseases},
year = {2026},
volume = {27},
number = {3-4},
pages = {139--149},
doi = {10.1111/1751-2980.70056}
}
EUVIMED